BMO’s Seigerman on Pfizer-Metsera deal: Bullish as we’ve waited on Pfizer’s foray into obesity
Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'The Exchange' to discuss Pfizer's obesity drug prospects, competitors and ...
Monday, October 6, 2025
Tag: BMOs
2025 is poised for a bull market despite negative sentiment, says BMO’s Brian Belski
Brian Belski, BMO Capital Markets chief investment officer, joins CNBC's 'Squawk on the Street' to discuss the markets moving higher ...
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.